Growth Metrics

Repligen (RGEN) Common Equity (2016 - 2025)

Repligen (RGEN) has disclosed Common Equity for 16 consecutive years, with $2.1 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 6.76% to $2.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 billion through Dec 2025, up 6.76% year-over-year, with the annual reading at $2.1 billion for FY2025, 6.76% up from the prior year.
  • Common Equity for Q4 2025 was $2.1 billion at Repligen, up from $2.1 billion in the prior quarter.
  • The five-year high for Common Equity was $2.1 billion in Q4 2025, with the low at $1.6 billion in Q1 2021.
  • Average Common Equity over 5 years is $1.9 billion, with a median of $2.0 billion recorded in 2023.
  • The sharpest move saw Common Equity surged 52.49% in 2021, then rose 0.4% in 2024.
  • Over 5 years, Common Equity stood at $1.8 billion in 2021, then increased by 9.18% to $1.9 billion in 2022, then increased by 2.83% to $2.0 billion in 2023, then grew by 0.4% to $2.0 billion in 2024, then grew by 6.76% to $2.1 billion in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $2.1 billion, $2.1 billion, and $2.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.